+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Swedish Orphan Biovitrum AB - logo

Swedish Orphan Biovitrum AB - Company & Market Research Reports

Following a company allows Research and Markets to customize your experience and provide personalized recommendations.

Sobi is a leading integrated biopharmaceutical company that focuses on developing therapies and treatments for haemophilia, inflammation, genetic and metabolic diseases. Its operations are split into three core areas: Core Products, Partner Products and ReFacto Manufacturing. The organisation spans 24 countries, delivering therapies to patients in 67 countries across the globe. However, Europe accounts for up to 54 per cent of its sales. Sobi is headquartered in Stockholm, Sweden.

From
From
From
From
From
From
Ulcerative Colitis - Pipeline Review, H2 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 542 Pages
From
Ulcerative Colitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 482 Pages
From
From
From
From
From
Loading Indicator
adroll